Hui Miao
Director/Board Member bei Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Aktive Positionen von Hui Miao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
 Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The private company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Director/Board Member | - | - |
Karriereverlauf von Hui Miao
Ehemalige bekannte Positionen von Hui Miao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Director/Board Member | 17.10.2022 | 09.04.2024 |
| Chief Executive Officer | 01.07.2022 | 09.04.2024 | |
| Corporate Officer/Principal | 01.07.2022 | 23.09.2022 | |
| President | 23.09.2022 | 09.04.2024 |
Ausbildung von Hui Miao
| Renmin University of China | Undergraduate Degree |
Statistik
International
| China | 4 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The private company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Health Technology |
